- Home
- CVKD vs STAI Comparison
CVKD vs STAI Comparison
Compare CVKD & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- STAI
- Stock Information
- Founded
- CVKD 2022
- STAI 2011
- Country
- CVKD United States
- STAI United States
- Employees
- CVKD N/A
- STAI N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- STAI
- Sector
- CVKD Health Care
- STAI
- Exchange
- CVKD Nasdaq
- STAI Nasdaq
- Market Cap
- CVKD 33.7M
- STAI N/A
- IPO Year
- CVKD 2023
- STAI N/A
- Fundamental
- Price
- CVKD $15.50
- STAI $1.46
- Analyst Decision
- CVKD Strong Buy
- STAI
- Analyst Count
- CVKD 1
- STAI 0
- Target Price
- CVKD $32.00
- STAI N/A
- AVG Volume (30 Days)
- CVKD 21.0K
- STAI 505.3K
- Earning Date
- CVKD 05-08-2025
- STAI 01-01-0001
- Dividend Yield
- CVKD N/A
- STAI N/A
- EPS Growth
- CVKD N/A
- STAI N/A
- EPS
- CVKD N/A
- STAI N/A
- Revenue
- CVKD N/A
- STAI $522,166.00
- Revenue This Year
- CVKD N/A
- STAI N/A
- Revenue Next Year
- CVKD N/A
- STAI N/A
- P/E Ratio
- CVKD N/A
- STAI N/A
- Revenue Growth
- CVKD N/A
- STAI N/A
- 52 Week Low
- CVKD $5.70
- STAI $1.23
- 52 Week High
- CVKD $22.90
- STAI $12.19
- Technical
- Relative Strength Index (RSI)
- CVKD 41.03
- STAI N/A
- Support Level
- CVKD $15.29
- STAI N/A
- Resistance Level
- CVKD $17.00
- STAI N/A
- Average True Range (ATR)
- CVKD 0.80
- STAI 0.00
- MACD
- CVKD -0.02
- STAI 0.00
- Stochastic Oscillator
- CVKD 9.50
- STAI 0.00
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.